US Stock MarketDetailed Quotes

FDMT 4D Molecular Therapeutics

Watchlist
  • 7.500
  • -0.120-1.57%
Close Nov 26 16:00 ET
  • 7.490
  • -0.010-0.13%
Post 17:14 ET
346.71MMarket Cap-2631P/E (TTM)

4D Molecular Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

4D Molecular Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 176.000K--
--2024/Q4-- / 2.201M--
--2024/Q33.000K / 601.140K--
--2024/Q25.000K / 685.710K--
--2024/Q128.000K / 915.710K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 176.000K--
--2024/Q4-- / 2.201M--
--2024/Q33.000K / 601.140K--
--2024/Q25.000K / 685.710K--
--2024/Q128.000K / 915.710K--

Unlock Free Earnings Estimates

4D Molecular Therapeutics Earnings Reports

  • 4D Molecular Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 13 16:34 ET

  • 4D Molecular Therapeutics | 8-K: 4DMT Reports Third Quarter 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones

    Nov 13 16:23 ET

  • 4D Molecular Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:24 ET

  • 4D Molecular Therapeutics | 8-K: 4DMT Reports Second Quarter 2024 Financial Results and Operational Highlights

    Aug 8 16:23 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 26, 2024

    Buy

    • Buy

      81.82%

    • Hold

      9.09%

    • Sell

      9.09%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data